Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Myocardial ultrasound tissue characterization of patients with primary aldosteronism.

Lee HH, Hung CS, Wu XM, Wu VC, Liu KL, Wang SM, Lin LC, Chen PC, Guo YL, Chueh SC, Lin YH, Ho YL, Wu KD; Taipai Study Group.

Ultrasound Med Biol. 2013 Jan;39(1):54-61. doi: 10.1016/j.ultrasmedbio.2012.08.023.

PMID:
23200178
2.

Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy.

Lin YH, Lee HH, Liu KL, Lee JK, Shih SR, Chueh SC, Lin WC, Lin LC, Lin LY, Chung SD, Wu VC, Kuo CC, Ho YL, Chen MF, Wu KD; TAIPAI Study Group.

Surgery. 2011 Sep;150(3):526-33. doi: 10.1016/j.surg.2011.02.006. Epub 2011 Apr 22.

PMID:
21514614
3.

Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.

Lin YH, Wu XM, Lee HH, Lee JK, Liu YC, Chang HW, Lin CY, Wu VC, Chueh SC, Lin LC, Lo MT, Ho YL, Wu KD; TAIPAI Study Group.

J Hypertens. 2012 Aug;30(8):1606-13. doi: 10.1097/HJH.0b013e3283550f93.

PMID:
22688266
4.

Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma.

Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C, Pessina AC.

Circulation. 1997 Mar 18;95(6):1471-8.

5.

Cardiac remodeling in patients with primary aldosteronism.

Galetta F, Bernini G, Franzoni F, Bacca A, Fivizzani I, Tocchini L, Bernini M, Fallahi P, Antonelli A, Santoro G.

J Endocrinol Invest. 2009 Oct;32(9):739-45. doi: 10.3275/6380. Epub .

PMID:
19564719
6.

Evidence of exercise-induced myocardial ischemia in patients with primary aldosteronism: the Cross-sectional Primary Aldosteronism and Heart Italian Multicenter Study.

Napoli C, Di Gregorio F, Leccese M, Abete P, Ambrosio G, Giusti R, Casini A, Ferrara N, De Matteis C, Sibilio G, Donzelli R, Montemarano A, Mazzeo C, Rengo F, Mansi L, Liguori A.

J Investig Med. 1999 May;47(5):212-21.

PMID:
10361380
7.

The relation among aldosterone, galectin-3, and myocardial fibrosis: a prospective clinical pilot follow-up study.

Liao CW, Lin YT, Wu XM, Chang YY, Hung CS, Wu VC, Wu KD, Lin YH; TAIPAI Study Group.

J Investig Med. 2016 Aug;64(6):1109-13. doi: 10.1136/jim-2015-000014. Epub 2016 May 17.

PMID:
27190071
8.

Echocardiographic comparison of left ventricular structure and function in hypertensive patients with primary aldosteronism and essential hypertension.

Goldkorn R, Yurenev A, Blumenfeld J, Fishman D, Devereux RB.

Am J Hypertens. 2002 Apr;15(4 Pt 1):340-5.

PMID:
11991220
9.

Association between urine aldosterone and diastolic function in patients with primary aldosteronism and essential hypertension.

Chang YY, Lee HH, Hung CS, Wu XM, Lee JK, Wang SM, Liao MT, Chen YH, Wu VC, Wu KD, Lin YH; TAIPAI Study Group.

Clin Biochem. 2014 Sep;47(13-14):1329-32. doi: 10.1016/j.clinbiochem.2014.05.062. Epub 2014 Jun 2.

PMID:
24892901
10.

Relationship between ultrasonic tissue characterization and myocardial deformation for prediction of left ventricular reverse remodelling in non-ischaemic dilated cardiomyopathy.

Park SM, Kim YH, Ahn CM, Hong SJ, Lim DS, Shim WJ.

Eur J Echocardiogr. 2011 Dec;12(12):887-94. doi: 10.1093/ejechocard/jer177. Epub 2011 Sep 20.

11.

Left ventricular structural and functional characteristics in patients with renovascular hypertension, primary aldosteronism and essential hypertension.

Yoshihara F, Nishikimi T, Yoshitomi Y, Nakasone I, Abe H, Matsuoka H, Omae T.

Am J Hypertens. 1996 Jun;9(6):523-8.

PMID:
8783775
12.

Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration.

Jakubik P, Janota T, Widimsky J Jr, Zelinka T, Strauch B, Petrak O, Benakova H, Bezdickova D, Wichterle D, Zima T, Hradec J.

Blood Press. 2006;15(5):302-7.

PMID:
17380848
13.

Adipokines and cardiometabolic profile in primary hyperaldosteronism.

Iacobellis G, Petramala L, Cotesta D, Pergolini M, Zinnamosca L, Cianci R, De Toma G, Sciomer S, Letizia C.

J Clin Endocrinol Metab. 2010 May;95(5):2391-8. doi: 10.1210/jc.2009-2204. Epub 2010 Mar 1.

PMID:
20194710
14.

Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: prediction of response to beta-blocker therapy.

Suwa M, Ito T, Kobashi A, Yagi H, Terasaki F, Hirota Y, Kawamura K.

Am Heart J. 2000 May;139(5):905-12.

PMID:
10783226
15.

[Ultrasonic integrated backscatter analysis in patients with dilated cardiomyopathy: comparison with healthy individuals].

Onbaşili OA, Tekten T, Ceyhan C, Ercan E.

Anadolu Kardiyol Derg. 2002 Mar;2(1):4-11, AXV. Turkish.

16.

Changes in left ventricular anatomy and function in hypertension and primary aldosteronism.

Rossi GP, Sacchetto A, Visentin P, Canali C, Graniero GR, Palatini P, Pessina AC.

Hypertension. 1996 May;27(5):1039-45.

17.

The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.

Prejbisz A, Postuła M, Cybulska I, Dobrucki T, Kabat M, Peczkowska M, Janas J, Janaszek-Sitkowska H, Makowiecka-Cieśla M, Januszkiewicz A.

Kardiol Pol. 2003 Jan;58(1):17-26.

PMID:
14502298
18.

Left ventricular systolic function in primary aldosteronism and hypertension.

Rossi GP, Sacchetto A, Pavan E, Scognamiglio R, Pietra M, Pessina AC.

J Hypertens. 1998 Dec;16(12 Pt 2):2075-7.

PMID:
9886899
19.

Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism.

Bernini G, Galetta F, Franzoni F, Bardini M, Taurino C, Bernardini M, Ghiadoni L, Bernini M, Santoro G, Salvetti A.

J Hypertens. 2008 Dec;26(12):2399-405. doi: 10.1097/HJH.0b013e32831286fd.

PMID:
19008719
20.

Ultrasound tissue characterization by integrated backscatter for analyzing Fluorouracil induced myocardial damage.

Ceyhan C, Meydan N, Barutca S, Tekten T, Onbasili AO, Ozturk B, Unal S.

Echocardiography. 2005 Mar;22(3):233-8.

PMID:
15725158
Items per page

Supplemental Content

Write to the Help Desk